The Xrcc3 protein, which is required for the homologous recombinational repair of damaged DNA, forms a complex with the Rad51C protein in human cells. Mutations in either the Xrcc3 or Rad51C gene cause extreme sensitivity to DNA-damaging agents and generate the genomic instability frequently found in tumors. In the present study, we found that the Xrcc3 segment containing amino acid residues 63±346, Xrcc3 63±346
INTRODUCTION
Homologous recombinational repair (HRR) is one of the major pathways to repair double-strand breaks (DSBs), which are frequently caused by exposure to various DNA-damaging agents, including ionizing radiation, crosslinking reagents and oxidative stress (1±3). DSBs are also induced during chromosomal DNA replication (4) . When cells are defective in HRR, unrepaired DSBs accumulate in chromosomes, resulting in genomic instability (5±7). In fact, single nucleotide polymorphisms (SNPs) and mutations in genes involved in HRR have been identi®ed in tumor cells (8, 9) .
In the key step of the HRR pathway, the homologouspairing step, a single-stranded DNA (ssDNA) tail derived from a DSB site invades the homologous double-stranded DNA (dsDNA) to form a heteroduplex. In Escherichia coli, the RecA protein catalyzes the homologous-pairing step (10, 11) . Two eukaryotic homologs of RecA, the Rad51 and Dmc1 proteins, which are conserved from yeast to human, have been identi®ed (12±15), and have been shown to catalyze homologous pairing in vitro (16±20). The Dmc1 protein functions only in meiotic cells, but the Rad51 protein is expressed in both meiotic and mitotic cells (12±15). In addition, ®ve Rad51 paralogs [Xrcc2 (21, 22) , Xrcc3 (22, 23) , Rad51B/hREC2/Rad51L1 (24±26), Rad51C/Rad51L2 (27) and Rad51D/Rad51L3 (26, 28, 29) ], which share 20±30% amino acid identity with Rad51, have been identi®ed in mammals.
The Xrcc2 and Xrcc3 genes were ®rst identi®ed as human genes that complement the DNA damage-sensitive hamster cell lines, irs1 and irs1SF, respectively (23,30±33) , and were con®rmed to be involved in HRR in vivo (34, 35) . Cells lacking Xrcc2 or Xrcc3 show extreme sensitivity to DNA crosslinking reagents, such as cisplatin, and ionizing radiation, and have signi®cantly increased chromosomal missegregation (22, 23, 36) . Knockout experiments in the chicken DT40 cell lines showed that the Rad51B, Rad51C and Rad51D genes are also involved in the HRR pathway as well as the Xrcc2 and Xrcc3 genes (37, 38) .
The ®ve Rad51 paralogs reportedly exist in two distinct complexes in human cells (39±42). One is composed of Rad51B, Rad51C, Rad51D and Xrcc2. This type of complex formation was predicted by the yeast two-and three-hybrid experiments (43) . The Xrcc2±Rad51D and Rad51B±Rad51C subcomplexes were also puri®ed as recombinant proteins (44, 45) . The Xrcc2±Rad51D complex has potential to catalyze homologous pairing between ssDNA fragment and superhelical dsDNA (44) . Although Rad51B does not catalyze homologous pairing by itself (46, 47) , the Rad51B±Rad51C complex functions in the homologous-pairing step to antagonize the RPA-dependent repression in strand exchange by Rad51 (45) . These results with the subunits of the Rad51B± Rad51C±Rad51D±Xrcc2 complex suggested that the complex functions in the homologous-pairing step of HRR.
Another Rad51-paralog complex found in human cells is composed of Xrcc3 and Rad51C (39±42). Interestingly, the two-hybrid screening with the human brain cDNA library showed that Xrcc2 and Xrcc3 independently interact with Rad51D and Rad51C, respectively, also suggesting that Xrcc2 and Xrcc3 exist in different complexes in brain cells (44, 48) . The puri®ed Xrcc3±Rad51C complex binds to ssDNA and dsDNA (48, 49) , and has the potential to catalyze homologous pairing (48) . Rad51C alone also promotes strand exchange between homologous single-stranded and double-stranded oligonucleotides, probably through its dsDNA destabilizing activity (47) , suggesting that Rad51C is a catalytic center for this type of homologous pairing. On the other hand, no biochemical analysis of Xrcc3 itself has been reported yet. The Xrcc3 variant allele, Thr241Met, is found with signi®cantly higher frequency in melanoma skin cancer and bladder cancer (50±52). However, no signi®cant effect on the HRR pathway with the Xrcc3 variant was detected in the cells (53) . Analyses of the domains and the amino acid residues required for the Rad51-paralog functions are important to understand the biological consequences of their SNPs and mutations.
In the present study, we performed a two-hybrid analysis with deletion mutants of Xrcc3 and Rad51C to identify the regions required for the Xrcc3±Rad51C interaction, and found that the N-terminal region (1±62 amino acids) of Xrcc3 is dispensable for Rad51C binding. On the other hand, the entire region of Rad51C, except for several residues in the N-terminus, is required for Xrcc3 binding. Biochemical analyses revealed that an Xrcc3 deletion mutant containing amino acid residues 63±346 (Xrcc3 63±346 ) forms a complex with Rad51C, and the Xrcc3 63±346 ±Rad51C complex can bind ssDNA and dsDNA as well as the full-length Xrcc3±Rad51C complex, although the DNA-binding ability of Rad51C alone is apparently lower than those of the complexes. A mutational analysis also showed that the Xrcc3 Phe249 residue, which is located on the solvent accessible surface when the Xrcc3 amino acids are superimposed on the RecA structure, is essential for Rad51C binding.
MATERIALS AND METHODS

Yeast two-hybrid analysis
The human Xrcc3 and Rad51C genes were cloned from human brain cDNA (purchased from Clontech) by the polymerase chain reaction (PCR). The DNA fragments encoding the Xrcc3 and Rad51C deletion mutants were designed based on secondary structure predictions, and were ampli®ed by the PCR method. Mutations at Phe30, Tyr139, Phe180, Phe219, Phe223 and Phe249 of Xrcc3 were introduced by the sitedirected mutagenesis method. The DNA fragments containing sequences derived from Xrcc3 were ligated into the NdeI site of the pAS2-1 vector (Clontech), and those containing sequences derived from Rad51C were ligated into either the SmaI or NcoI site of the pACT2 vector (Clontech). Plasmids pAS2-1 and pACT2 contain the GAL4 DNA-binding domain and the GAL4 activation domain, respectively, just upstream of their multiple cloning sites. The pAS2-1 vector containing the Xrcc3 sequence was introduced into the yeast strain AH109 and the pACT2 vector containing the Rad51C sequence was introduced into the yeast strain Y187. Twohybrid interactions between Xrcc3 and Rad51C were tested by mating the AH109 and Y187 strains, according to the manufacturer's protocol (Clontech Matchmaker GAL4 protocol). The interaction between Xrcc3 and Rad51C induced the expressions of the HIS3 and LacZ reporter genes, which were detected by yeast growth on a synthetic dextrose minimal medium (SD) plate without histidine and by b-galactosidase activity using a 5-bromo-4-chloro-3-indolyl-b-D-galactoside (X-Gal) ®lter assay, respectively.
Puri®cation of the Xrcc3 63±346 ±Rad51C complex
The Xrcc3±Rad51C complex and Rad51C were puri®ed as described previously (48) . The DNA fragments containing Xrcc3 63±346 and Rad51C were inserted into the pET15b vector at the NcoI and NdeI sites, respectively. Then, the pET15b vector containing the Rad51C sequence was digested with BglII and BamHI, and the fragment with Rad51C was ligated into the BamHI site of the pET15b-Xrcc3 63±346 vector. The over-expression plasmid for Xrcc3 63±346 and Rad51C was introduced into E.coli JM109 (DE3) cells with the plasmid containing the genes for E.coli tRNA Arg 3 and tRNA Arg 4 , which recognize the CGG and AGA/AGG codons, respectively. The cells were grown in 10 l of LB medium containing 100 mg/ml ampicillin and 34 mg/ml chloramphenicol at 30°C for 10 h, and then 200 mM isopropyl b-thiogalactopyranoside (IPTG) was added to induce protein expression. Xrcc3 63±346 and Rad51C were produced for 12 h at 18°C in the presence of IPTG, and the cells were harvested. The Rad51C protein contains a His 6 -tag and the Xrcc3 63±346 protein contains a FLAG-tag at the N-terminus. The cells producing Xrcc3 63±346 and Rad51C were resuspended in 20 ml of 20 mM sodium phosphate buffer (pH 8.5) containing 0.5 M NaCl, and were disrupted by sonication. The samples were centrifuged for 20 min at 30 000 g and the supernatants were incubated with 4 ml of Ni-NTA agarose (Qiagen) for 1 h at 4°C. Then, the Xrcc3 63±346 and Rad51C-bound resin was packed into a column and was washed with 300 ml of 20 mM Tris±HCl buffer (pH 8.5) containing 10 mM imidazole and 0.5 M NaCl. Subsequently, the resin was washed with 150 ml of 20 mM Tris±HCl buffer (pH 8.5) containing 10 mM imidazole. Xrcc3 63±346 and Rad51C were eluted by a gradient of imidazole from 10 to 400 mM in 20 mM Tris±HCl buffer (pH 8.5). The samples eluted from the Ni-column were applied to a heparin±Sepharose column (Amersham Biosciences) previously equilibrated with 20 mM Tris±HCl buffer (pH 8.5) containing 2 mM dithiothreitol and 10% glycerol. The proteins were eluted by a gradient of NaCl from 0 to 1200 mM and were dialyzed against 20 mM Tris±HCl buffer (pH 8.1) containing 5 mM dithiothreitol and 10% glycerol. The protein concentration was determined by the Bio-Rad protein assay kit (Bio-Rad), using bovine serum albumin (BSA) as the standard protein.
Preparation of closed circular double-stranded DNA
To avoid irreversible denaturation of the dsDNA, we prepared the plasmid DNA without any treatment that would potentially cause denaturation, such as alkaline treatment. The plasmid DNA (pGsat4; 3216 bp) containing the human a-satellite sequence was introduced into the E.coli DH5a strain and the cells were cultured for 12±16 h at 37°C. The cells were harvested, mildly disrupted with 0.5 mg/ml lysozyme and 0.1% sarkosyl, and centrifuged at 92 000 g for 1 h. The supernatant containing the pGsat4 plasmid DNA was extracted with phenol/chloroform three times, and the pGsat4 DNA in the aqueous phase was precipitated by ethanol. The pellet was dissolved in 1 ml of TE buffer and was treated with 0.15 mg/ml RNaseA at 37°C for 30 min. The pGsat4 DNA was puri®ed by a 5±20% sucrose gradient centrifugation at 98 000 g for 18 h. DNA concentrations are expressed in moles of nucleotides.
Preparation of circular single-stranded DNA
The E.coli cells (JM109) containing pGsat4 DNA were cultured in LB medium until an A 660 of 0.3 was achieved, and were then infected with the helper phage R408 at an multiplicity of infection (m.o.i.) of~20. After infection, the cells were continuously cultured for 6 h with vigorous agitation. Then, the supernatant was harvested and was treated with DNase I (10 U/ml) and RNase A (10 mg/ml) for 15 min at 37°C. The phage containing pGsat4 ssDNA was precipitated by adding 0.25 vol of phage precipitation solution, containing 3.75 M ammonium acetate (pH 7.5) and 20% polyethylene glycol 8000. The resulting pellet was resuspended in TE buffer, and the pGsat4 ssDNA was extracted with chloroform: isoamyl alcohol (24:1) followed by phenol:chloroform saturated with TE buffer. After several phenol:chloroform extractions, the aqueous phase was extracted with chloroform and the pGsat4 ssDNA was precipitated with 2 vol of ethanol in the presence of 3.25 M ammonium acetate. The resulting pellet was rinsed with 70% ethanol and was dried under vacuum. The pGsat4 ssDNA was dissolved in H 2 O, and its concentration is expressed in moles of nucleotides.
Single-stranded DNA binding assay
Single-stranded pGsat4 DNA (40 mM) was mixed with Xrcc3±Rad51C, Xrcc3 63±346 ±Rad51C or Rad51C in 10 ml of standard reaction buffer, containing 20 mM Tris±HCl (pH 8.1), 2 mM ATP, 1 mM dithiothreitol, 100 mg/ml BSA, 2 mM MgCl 2 and 3% glycerol. Protein concentrations were 0.35, 0.7 and 1.1 mM. The reaction mixtures were incubated at 37°C for 10 min, and were analyzed by 0.8% agarose gel electrophoresis in 0.5Q TBE buffer (45 mM Tris-borate and 1 mM EDTA). The bands were visualized by ethidium bromide staining.
Double-stranded DNA binding assay
Superhelical pGsat4 DNA (15 mM; 3216 bp) was mixed with Xrcc3±Rad51C, Xrcc3 63±346 ±Rad51C or Rad51C in 10 ml of standard reaction buffer, containing 20 mM Tris±HCl (pH 8.1), 2 mM ATP, 1 mM dithiothreitol, 100 mg/ml BSA, 2 mM MgCl 2 and 3% glycerol. Protein concentrations were 0.35, 0.7 and 1.1 mM. The reaction mixtures were incubated at 37°C for 10 min, and the samples were electrophoresed on a 0.8% agarose gel for 4 h at 3 V/cm in 0.5Q TBE buffer (45 mM Tris-borate and 1 mM EDTA). The bands were visualized by ethidium bromide staining.
Ni-bead pull-down assay
Co-expression vectors for Xrcc3 (or the Xrcc3 point mutants) and Rad51C were introduced into E.coli JM109 (DE3) cells with the plasmid containing the genes for E.coli tRNA Arg 3 and tRNA Arg 4 . The freshly transformed cells were grown in 10 ml of LB medium at 30°C to an OD 600 of 0.5, and protein expression was induced with 200 mM IPTG at 18°C for 12 h. The cell pellets were resuspended in 200 ml of 20 mM Tris±HCl buffer (pH 7.8) containing 0.5 M NaCl and 200 mg/ml lysozyme, and were lysed for 30 min on ice. The samples were centrifuged at 30 000 g for 10 min, and the supernatants (200 ml) were mixed with 40 ml of ProBond beads (50% slurry; Invitrogen) at 4°C for 1 h. Then, the beads were washed three times with 500 ml of 20 mM Tris±HCl buffer (pH 7.8) containing 0.5 M NaCl and the proteins bound to the beads were fractionated by 15±25% gradient SDS±PAGE. Bands were visualized by Coomassie brilliant blue staining.
Immuno-precipitation assay
Co-expression vectors for Xrcc3 (or the Xrcc3 point mutants) and Rad51C were introduced into E.coli BL21 CodonPlus cells (Stratagene). The freshly transformed cells were grown in 5 ml of LB medium at 30°C to an OD 600 of 0.5, and protein expression was induced with 200 mM IPTG at 18°C for 12 h. The cell pellets were resuspended in 500 ml of 20 mM Tris±HCl buffer (pH 8.5) containing 0.5 M NaCl and 2 mg/ml lysozyme, and were disrupted by sonication. The samples were centrifuged at 17 000 g for 10 min, and the supernatants (100 ml) were mixed with 10 ml of anti-Rad51C antibodyconjugated rProtein A Sepharose Fast Flow (Amersham Biosciences) at 4°C for 2 h. Then, the beads were washed three times with 500 ml of phosphate buffer saline containing 1% NP-40. The proteins bound to the beads were eluted with 50 ml of ImmunoPure IgG elution buffer (Pierce), and were detected by the western blotting method using the antiRad51C or anti-Xrcc3 polyclonal antibody.
RESULTS
Deletion analysis of the Xrcc3 and Rad51C regions required for their interaction
In order to study the Rad51C-interacting region of Xrcc3, we constructed 12 Xrcc3 deletion mutants, Xrcc3 10±346 , Xrcc3 20±346 , Xrcc3 31±346 , Xrcc3 41±346 , Xrcc3 63±346 , Xrcc3 85±346 , Xrcc3 1±223 , Xrcc3 1±250 , Xrcc3 1±270 , Xrcc3 1±308 , Xrcc3 1±320 and Xrcc3 1±337 , which were composed of amino acid residues 10±346, 20±346, 31±346, 41±346, 63±346, 85±346, 1±223, 1±250, 1±270, 1±308, 1±320 and 1±337, respectively (Fig. 1A) . These Xrcc3-deletion mutants were tested for their abilities to interact with Rad51C by the yeast two-hybrid analysis. In this system, the Xrcc3±Rad51C interaction induces the expressions of the HIS3 and LacZ reporter genes, which allow the yeast strain to grow in the absence of histidine (Fig. 1B, lane 2 , middle row) and with blue color in the presence of X-Gal (Fig. 1B, lane 2, bottom  row) . As shown in Figure 1B , ®ve N-terminally truncated Xrcc3 mutants, Xrcc3 10±346 , Xrcc3 20±346 , Xrcc3 31±346 , Xrcc3 41±346 and Xrcc3 63±346 , were able to interact with Rad51C as well as the full-length Xrcc3 (lanes 2±7); however, Xrcc3 85±346 , which lacked the N-terminal 84 amino acid residues, did not interact with Rad51C (lane 8). These results indicate that the N-terminal 62 amino acid residues of Xrcc3 are not involved in Rad51C binding. In contrast, none of the C-terminally truncated Xrcc3 mutants interacted with Rad51C, and even Xrcc3 1±337 , which lacked only nine amino acids from the C-terminal end, did not interact with Rad51C (Fig. 1B, lanes 9±14) . Therefore, the C-terminal segment of residues 63±346 is the Rad51C-binding region of Xrcc3.
Next, we analyzed the Xrcc3-interacting region of Rad51C. Based on the secondary structure prediction, six N-terminally and six C-terminally truncated Rad51C mutants were constructed (Fig. 1C) , and were tested for their abilities to interact with Xrcc3 by the two-hybrid analysis. As shown in Figure 1D , only one Rad51C deletion mutant, which lacked seven amino acid residues from the N-terminal end, interacted with Xrcc3. Therefore, the entire region of Rad51C, except for several N-terminal residues, is required for the Xrcc3 binding. These Rad51C deletion mutants may be defective in the proper folding of the protein. It has been reported that the DNA damage-sensitive hamster cell lines, CL-V4B and irs3, have mutations in the Rad51C gene, and are probably missing exon 5 and exon 6, respectively (54, 55) . Exon 5 and exon 6 of the Rad51C gene encode the amino acid residues from Val236 and Val280, respectively. As shown in Figure 1D , Rad51C 1±234 and Rad51C 1±291 , which lack the C-terminal regions from Lys235 and Arg292, respectively, were defective in the Xrcc3 interaction (lanes 10 and 11) . The DNA damagesensitive phenotypes of CL-V4B and irs3 may be due to a defective interaction between the Xrcc3 and Rad51C mutants.
The Xrcc3 deletion mutant, Xrcc3 63±346 , forms a complex with Rad51C
To determine whether Xrcc3 63±346 directly interacts with Rad51C, we co-expressed Xrcc3 63±346 with the His 6 -tagged Rad51C proteins in E.coli cells, and studied their interaction using Ni-nitrilotriacetate (Ni-NTA) agarose column chromatography. As shown in Figure 2A , Xrcc3 63±346 , which did not contain a His 6 tag, co-eluted with the His 6 -tagged Rad51C protein from the Ni-NTA agarose column. Both the Xrcc3 63±346 and Rad51C proteins were further co-puri®ed by heparin±Sepharose column chromatography (Fig. 2B, lane 3) . Therefore, these results indicate that Xrcc3 63±346 directly binds to Rad51C. Xrcc3 63±346 was not detected in the soluble fraction when it was expressed alone, suggesting that the complex formation with Rad51C is required for the proper folding of Xrcc3 63±346 .
The DNA-binding activity of Xrcc3 63±346 ±Rad51C
Next, we tested the DNA-binding ability of the puri®ed Xrcc3 63±346 ±Rad51C complex. It was reported that the Xrcc3±Rad51C complex binds ssDNA and dsDNA (48, 49) , and that the DNA-binding ability of Rad51C alone is lower than that of Xrcc3±Rad51C (48) . In the present study, pGsat4 circular ssDNA (3216 bases) and pGsat4 superhelical dsDNA (3216 bp) were used as substrates for DNA binding by Xrcc3 63±346 ±Rad51C. Consistent with previous observations (47, 48) , both Xrcc3±Rad51C and Rad51C alone bound to ssDNA and dsDNA, but the ssDNA-and dsDNA-binding abilities of Rad51C alone were signi®cantly lower than that of Xrcc3±Rad51C (Fig. 3) . Interestingly, Xrcc3 63±346 ±Rad51C bound to ssDNA and dsDNA as well as Xrcc3±Rad51C (Fig. 3) . Therefore, Xrcc3 63±346 contains the functional domain, which is important in the DNA binding of Xrcc3±Rad51C. It should be noted that the ssDNA binding of Rad51C alone was clearly detected with short singlestranded oligonucleotides (47) . However, Rad51C binding to the long circular ssDNA (3216 bases) was poorly observed (48) (Fig. 3) . Xrcc3 may be required in cooperative binding of Rad51C to the long DNA.
Design of mutations in Xrcc3
To identify the amino acid residues involved in the Xrcc3±Rad51C interaction, we constructed six mutant Xrcc3 genes, F30A, Y139A, F180A, F219A, F223A and F249A, each with an alanine replacement at positions Phe30, Tyr139, Phe180, Phe219, Phe223 and Phe249, respectively. Phenylalanine and tyrosine were selected as amino acids for mutagenesis, because these aromatic residues were frequently found at the protein±protein interface. As shown in Figure 4A , Tyr139 of Xrcc3 is perfectly conserved as an aromatic residue among the RecA/Rad51-class proteins (the human Rad51B, Rad51C, Rad51D, Rad51 and Dmc1 proteins, and the E.coli RecA protein). Phe180 of Xrcc3 is also highly conserved, and Phe219, Phe223 and Phe249 of Xrcc3 are partially conserved among the RecA/Rad51-class proteins (Fig. 4A ). When these Xrcc3 amino acid residues were superimposed on the crystal structure of RecA (56), Tyr139, corresponding to Phe92 in RecA, was located inside the RecA molecule (Fig. 4B, red  sphere) , where it probably forms the hydrophobic core of the protein. Phe180, Phe219, Phe223 and Phe249 of Xrcc3 were located on the molecular surface of the RecA structure (Fig. 4B , yellow, green, blue, and pink spheres, respectively). Therefore, these residues are considered as candidates that are directly involved in the interface between Xrcc3 and Rad51C. The Xrcc3 F30A mutant was designed as a negative control, which has an amino acid replacement outside the Rad51C-interacting region of Xrcc3 (amino acid residues 63±346). These six Xrcc3 mutants were tested for their interactions with Rad51C. 
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Two-hybrid analysis of interactions between the Xrcc3 point mutants and Rad51C
First, we tested the two-hybrid interactions between the Xrcc3 point mutants and Rad51C. As expected, Xrcc3 F30A, which has a mutation outside the Rad51C-interacting region, positively interacted with Rad51C as well as the wild-type Xrcc3 (Fig. 5, lanes 2 and 3) . The Xrcc3 F180A, F219A and F223A mutants were also positive in Rad51C binding (Fig. 5, lanes  5±7) . These results indicate that Phe180, Phe219 and Phe223 of Xrcc3 are not involved in the Xrcc3±Rad51C interaction, although these residues are located on the solvent accessible surface in the model structure (Fig. 4B) . In contrast, the Xrcc3 Y139A and F249A mutants did not show positive signals, suggesting that these mutants are defective in Rad51C binding (Fig. 5, lanes 4 and 8) . Therefore, Tyr139 and Phe249 may be essential amino acid residues for Rad51C binding.
Tyr139 and Phe249 of Xrcc3 are essential for Rad51C binding
In order to con®rm the results from the two-hybrid analysis with the Xrcc3 point mutants, we performed two independent assays, the Ni-bead pull-down and immuno-precipitation assays, with cell-free extracts containing the His 6 -tagged Rad51C protein and one of the FLAG-tagged Xrcc3 mutants. Cell-free extracts were prepared from the E.coli cells, in which each of the six FLAG-tagged Xrcc3 mutants was co-expressed with the His 6 -tagged Rad51C protein (Fig. 6A) . In the Ni-bead pull-down assay, the Xrcc3 protein should coprecipitate with the His 6 -tagged Rad51C protein by the Ni-chelating beads (ProBond), if it was directly bound to Rad51C. As shown in Figure 6B , the wild-type Xrcc3 protein coprecipitated with the His 6 -tagged Rad51C protein (lane 1). Consistent with the results from the two-hybrid analysis, the Xrcc3 F30A, F180A, F219A and F223A mutants coprecipitated with the His 6 -tagged Rad51C protein as well as the wild-type Xrcc3 protein, indicating that these mutants were pro®cient in Rad51C binding (Fig. 6B, lanes 1, 2 and 4±6 ). On the other hand, the Xrcc3 Y139A and F249A mutants, which did not show an interaction with Rad51C in the two-hybrid analysis, exhibited a signi®cant de®ciency in Rad51C binding in the Ni-bead pull-down assay (Fig. 6B, lanes 3 and 7) .
Consistent results were obtained with the immunoprecipitation assay using a polyclonal antibody against Rad51C. As shown in Figure 6C , Rad51C was speci®cally precipitated with the anti-Rad51C antibody from the extracts expressing both Xrcc3 (or a Xrcc3 mutant) and Rad51C. When protein fractions precipitated with the anti-Rad51C antibody were probed with a polyclonal antibody against Xrcc3, the Xrcc3 F30A, F180A, F219A and F223A mutants were detected as well as the wild-type Xrcc3 protein. In contrast, the amounts of the Xrcc3 Y139A and F249A mutants that were coprecipitated with Rad51C by the anti-Rad51C antibody were signi®cantly decreased (Fig. 6D, lanes 3 and 7) . All of these results from the three independent experiments, the two-hybrid analysis, the Ni-bead pull-down assay and the immuno-precipitation assay, are perfectly consistent with each other. Therefore, we conclude that Tyr139 and Phe249 of Xrcc3 play essential roles in Rad51C binding.
DISCUSSION
In the present study, we identi®ed the Xrcc3 segment from amino acid residues 63±346 as the Rad51C-interacting region. This region contains the Walker-type ATPase motifs, which are highly conserved among seven human Rad51-class proteins, Rad51, Dmc1, Rad51B, Rad51C, Rad51D, Xrcc2 and Xrcc3 (57) . Recently, the crystal structure of the human Rad51 region (amino acid residues 97±339) was determined (58) , which revealed that the structure of this Rad51 core region is quite similar to that of RecA. Therefore, Xrcc3 63±346 may also share a similar core region structure with those of the Rad51 and RecA proteins, although this region of Xrcc3 has the speci®c function to interact with Rad51C.
Mutational analyses of Xrcc3 identi®ed Tyr139 and Phe249 as essential residues for Rad51C binding. Tyr139 of Xrcc3 was perfectly conserved among the Rad51/RecA-class proteins as an aromatic residue (Fig. 4A) . When Tyr139 of Xrcc3 was superimposed on the RecA crystal structure, the residue was located deep inside the protein molecule (Fig. 4B , red sphere). Since the amino acid residues that directly interact with Rad51C must be located on the surface of the protein molecule, the Xrcc3 Y139A mutation may indirectly affect the Rad51 binding, probably through a perturbation of the Xrcc3 structure. Actually, in the RecA structure, Phe92, corresponding to Tyr139 of Xrcc3, forms a hydrophobic core with Leu77, Ile80, Leu99, Ile111 and Leu114 (56) . So far, no mutations at the hydrophobic core of RecA has been reported. Interestingly, these hydrophobic residues are also conserved in Xrcc3, as Leu120, Pro127, Phe146, Leu170 and Leu173, respectively. The formation of the hydrophobic core around Tyr139 may be a key step in the proper folding of Xrcc3. The amino acid residue corresponding to Xrcc3 Tyr139 may be a central residue in the proper folding of the Rad51-class proteins.
In contrast, Phe249 of Xrcc3 was located on the surface of the protein molecule, when the residues were superimposed on the RecA structure (Fig. 4B, pink sphere) . The mutation of Phe249 in Xrcc3 caused a signi®cant decrease in the Rad51C-binding ability as evaluated by three independent assays, the two-hybrid analysis, the Ni-bead pull-down assay and the immuno-precipitation assay. Therefore, Phe249 of Xrcc3 is a strong candidate for one of the amino acid residues that constitute the interface for Rad51C binding. Interestingly, Phe249 of Xrcc3 is conserved in Rad51 as Phe259, which is an essential residue for Rad52 binding (59) . The Rad51 Phe259 residue is located in the solvent accessible surface, when it is superimposed on the polymer structure of RecA (59) . The Xrcc3 region around Phe249 is the protein-interacting region, which may have commonly evolved as a protein-binding surface among the eukaryotic Rad51-class proteins. Intriguingly, a variant Xrcc3 gene, T241M, is associated with an increased risk of cancer (52) . The Xrcc3 T241M variant has methionine instead of threonine at position 241, which is located very close to Phe249, suggesting that the variant may perturb the proper Xrcc3±Rad51C interaction. An in vivo study of the Xrcc3 T241M variant revealed that it can complement the Xrcc3-de®cent phenotypes in mammalian cells (53) . This small modi®cation on the Rad51C-interacting region in the Xrcc3 T241M variant may increase the risk of undesirable correction during DNA repair through homologous recombination.
In addition to the homologous-pairing step, Xrcc3 also reportedly functions in later stages of the HRR pathway, such as in the resolution of intermediates formed by homologous pairing (60) . Among the Rad51 paralogs, Rad51B preferentially binds a synthetic Holliday junction, which mimics an intermediate formed by homologous pairing (46) . Rad51B forms a stable complex with Rad51C, like Xrcc3. Rad51C may also function in the later stages of the HRR pathway with Xrcc3 and Rad51B. Further studies are required to understand these broad functional spectra of the Rad51 paralogs in the HRR pathway.
